header logo image

Efficacy of 23-Valent Pneumococcal Vaccine in Rheumatoid Arthritis Questioned – Infectious Disease Advisor (registration)

February 22nd, 2017 5:41 pm
Efficacy of 23-Valent Pneumococcal Vaccine in Rheumatoid Arthritis Questioned
Infectious Disease Advisor (registration)
The 23-valent pneumococcal polysaccharide vaccine (PPSV23) may not be effective for preventing pneumonia in patients with rheumatoid arthritis (RA) who are at risk for infections, according to a study published in Arthritis Research & Therapy.

Read the original:
Efficacy of 23-Valent Pneumococcal Vaccine in Rheumatoid Arthritis Questioned - Infectious Disease Advisor (registration)

Related Post

Comments are closed.


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick